10/26/2026
A new imaging system developed by Purdue Institute for Cancer Research investigator David Nolte is being used to assess experimental chemotherapy drugs for osteosarcoma, with the goal of identifying treatments best suited to individual tumors.
https://purdue.link/nolte-doppler-chemo-26